Digital Health Global
JANUARY 9, 2024
The funding speaks to the global nature of pre-approval access and its increasing importance in the drug development process. “ Our mutual dedication to building new approaches to pharmaceutical drug development and patient care will help bring promising pre-approval medicine to patients around the world, faster and more equitably.
Society for Participatory Medicine
FEBRUARY 1, 2023
The FDA issued a series of four patient-focused drug development (PFDD) guidance documents which outline how patient co-design needs to successfully happen. You may now kiss the cancer survivor. She is currently contracted by Parexel as their first Patient Ambassador.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Digital Health Global
SEPTEMBER 28, 2023
Investments will focus on the next generation of pharma R&D to accelerate drug development, on new technology solutions enabling a more patient-centric approach in clinical trials, and on digital platforms uncovering new insights from clinical data for more personalized care pathways.
Healthcare IT Today
NOVEMBER 6, 2023
About AllStripes Founded in 2017, AllStripes is a healthcare technology company dedicated to unlocking new treatments for people with rare diseases. To learn more about why 80% of the top Biopharma companies partner with PicnicHealth or to view our 35+ publications, visit picnichealth.com.
Lloyd Price
JUNE 17, 2023
Billed as the first and largest telemedicine company in the United States, Teladoc Health was launched in 2002 and has acquired companies such as BetterHelp in 2015, Best Doctors in 2017, and Advance Medical in 2018. Teladoc continued to grow, and by 2017 it was providing services to over 3 million patients.
DrKumo Remote Patient Monitoring
APRIL 12, 2022
Though the drug metformin (a biguanide formed by the fusion of two guanidines) was developed in 1922 by Wermer and Bell, it was the efforts of the French physician Jean Sterne that paved the way for the use of metformin as a glucose-lowering drug. Diabetologia 60, 1566–1576 (2017). Diabetologia 60, 1620–1629 (2017).
Lloyd Price
DECEMBER 8, 2018
billion valuation in the last fundraising in early 2017, according to Lagniappe. But key facets of its business didn’t develop as planned, say people familiar with the company. It had hoped to sell analytics to pharmaceutical companies as they increasingly incorporated genetic sequencing into drug development, these people say.
Expert insights. Personalized for you.
88 
Let's personalize your content